CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

← H01.0

Chapter 7 - Diseases of the eye and adnexa (H00-H59)»Disorders of eyelid, lacrimal system and orbit (H00-H05)»Unspecified blepharitis (H01.00)

H01.00

Unspecified blepharitis

Sub-codes (9)

  • H01.001 Unspecified blepharitis right upper eyelid
  • H01.002 Unspecified blepharitis right lower eyelid
  • H01.003 Unspecified blepharitis right eye, unspecified eyelid
  • H01.004 Unspecified blepharitis left upper eyelid
  • H01.005 Unspecified blepharitis left lower eyelid
  • H01.006 Unspecified blepharitis left eye, unspecified eyelid
  • H01.009 Unspecified blepharitis unspecified eye, unspecified eyelid
  • H01.00A Unspecified blepharitis right eye, upper and lower eyelids
  • H01.00B Unspecified blepharitis left eye, upper and lower eyelids

Related indications (MeSH) (1)

Blepharitis37 drugs (24 approved, 13 experimental)

Inflammation of the eyelids.

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.